Techbase Medical Defense (Applied Research)

Abstract

Project TM2 provides for applied research for innovative technology approaches to advance medical systems designed to rapidly identify, diagnose, prevent, and treat disease due to exposure to chemical and biological threat agents. After FY 2022, the Chemical Biological Defense Program (CBDP) RDT&E Projects were restructured to align with the CBDP portfolio construct. TM2 efforts in FY 2022 progress to Projects MT2, PT2, and UN2. This restructuring provides standardization and alignment across CBDP research, development and acquisition efforts. Individual efforts in this Project include: - Core science efforts in Medical Chemical, Medical Biological, Diagnostics, and Medical Countermeasures. - Supports applied research for the investigation of new medical countermeasures to include prophylaxes, pretreatments, antidotes, skin decontaminants, and therapeutic drugs against identified and emerging biological and chemical warfare agents. - Medical Science and Technology (S&T) efforts in this Budget Activity refine promising medical initiatives identified in Budget Activity 1, resulting in the development of countermeasures to protect against and treat the effects of exposure to chemical and biological (CB) agents. - Diagnostic research focuses on providing high quality data closer to the point-of-need comprising device innovation, panels of biomarkers driven by bioinformatics, and epidemiological modeling tools.

Document Details

• Document Type: Project
• Publication Date: Oct 01, 2024
• Source ID: TM2_0602384BP_2_0400_PB_2024

Tags

Readers

• Critical Infrastructure Protection in CBRN and WMD Threats.